AI Analysis AI Analysis of RDY
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Dr Reddy's Laboratories Ltd stock downgraded to Sell Candidate
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Nov 17, 2025

The Dr Reddy's Laboratories Ltd stock price gained 0.143% on the last trading day (Monday, 17th Nov 2025), rising from $13.94 to $13.96. It has now gained 6 days in a row. It is not often that stock manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 2.44% from a day low at $13.71 to a day high of $14.05. The price has risen in 8 of the last 10 days and is up by 4.1% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 104 thousand more shares were traded than the day before. In total, 982 thousand shares were bought and sold for approximately $13.71 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.45% during the next 3 months and, with a 90% probability hold a price between $12.59 and $14.02 at the end of this 3-month period.

RDY Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, October 31, 2025, and so far it has risen 5.04%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Dr Reddy's Laboratories Ltd stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $14.03. On a fall, the stock will find some support from the short-term average at $13.77. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Dr Reddy's Laboratories Ltd stock

Dr Reddy's Laboratories Ltd finds support from accumulated volume at $13.47 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.335 between high and low, or 2.44%. For the last week, the stock has had daily average volatility of 1.72%.

Since the Dr Reddy's Laboratories Ltd has been rising for 6 days in a row, the risk over the next couple of days has increased.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RDY) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Dr Reddy's Laboratories Ltd to open at $13.91, and during the day (based on 14 day Average True Range), to move between $13.83 and $14.09, which gives a possible trading interval of +/-$0.250 (+/-1.81%) up or down from last closing price. If Dr Reddy's Laboratories Ltd takes out the full calculated possible swing range there will be an estimated 1.81% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $13.97 (0.07%) than the support at $13.47 (3.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Dr Reddy's Laboratories Ltd stock A Buy?

Dr Reddy's Laboratories Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -2.382 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $13.91 ( 0.394%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

RDY Performance

Trading levels for RDY

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 14.24 2.01%
R2 14.11 1.09%
R1 14.03 0.523%
Price 13.96
S1 13.78 -1.31%
S2 13.70 -1.88%
S3 13.57 -2.79%

Accumulated Volume Support & Resistance Levels

Level Price
R3 14.58 4.44%
R2 14.20 1.72%
R1 13.97 0.0716%
Price 13.96
S1 13.47 -3.51%
S2 13.41 -3.94%
S3 13.29 -4.80%

RDY Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 25, 2025 Jul 25, 2025 Jul 25, 2025 $0.0731 0.485%
2 Jul 30, 2024 Jul 30, 2024 Jul 30, 2024 $0.407 2.52%
3 May 11, 2023 Jul 28, 2023 Aug 06, 2023 $0.488 3.53%
4 May 11, 2023 Jul 07, 2023 Aug 07, 2023 $0.488 3.53%
5 May 24, 2022 Aug 01, 2022 Aug 12, 2022 $0.378 3.52%

FAQ

What is the symbol for Dr Reddy's Laboratories Ltd Stock and on which exchange is it traded?
The symbol for Dr Reddy's Laboratories Ltd is RDY and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Dr Reddy's Laboratories Ltd Stock?
Dr Reddy's Laboratories Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Dr Reddy's Laboratories Ltd Stock?
Dr Reddy's Laboratories Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Dr Reddy's Laboratories Ltd Stock.

What's the current price of Dr Reddy's Laboratories Ltd Stock?
As of the end of day on the Nov 17, 2025, the price of an Dr Reddy's Laboratories Ltd (RDY) share was $13.96.

What is the 52-week high and low for Dr Reddy's Laboratories Ltd Stock?
The 52-week high for Dr Reddy's Laboratories Ltd Stock is $16.17 and the 52-week low is $12.26.

What is the market capitalization of Dr Reddy's Laboratories Ltd Stock?
As of the Nov 17, 2025, the market capitalization of Dr Reddy's Laboratories Ltd is 11.622B.

When is the next earnings date for Dr Reddy's Laboratories Ltd?
The upcoming earnings date for Dr Reddy's Laboratories Ltd is Jan 22, 2026.
Click to get the best stock tips daily for free!
ABOUT DR REDDY'S LABORATORIES LTD
Dr Reddy's Laboratories
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finish...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE